Botswana Harvard Research at AIDS 2016

bhp hai aids 2016

Researchers from the Harvard AIDS Initiative and the Botswana Harvard AIDS Institute made significant contributions to the 21st International AIDS Conference (AIDS 2016), held July 18-22, in Durban, South Africa. Here is a list of their presentations:

Sessions

Dr. Tendani Gaolathe
Dr. Tendani Gaolathe

Taking TB from Testing to Treatment
Co-chair: Tendani Gaolathe

Going Viral for Viral Load Implementation
Monitoring of HIV-1 RNA with point-of-care cepheid Xpert HIV-1 viral load in rural African communities is feasible and reliable in the era of broad scale up of ART
Sikhulile Moyo

Measuring Progress Towards 90-90-90
Cross-sectional estimates of HIV incidence remain high in rural communities in Botswana in the era of successful scale up of ART
Sikhulile Moyo

Past, Present and Future of HIV/AIDS in Resource-Limited Settings
Implementation science: The Test & Treat approach in resource-limited settings
Tendani Gaolathe

Abstracts

Erik van Widenfelt
Erik van Widenfelt

Simplifying data management for household-level combination prevention research in resource-limited settings with reusable open-source software: developing and deploying an electronic research data system for the Botswana Combination Prevention Project
Presenter: Erik van Widenfelt

Stand-alone health data systems in remote ART clinics in Botswana can be centralized over inexpensive low-bandwidth connections: the example of the Botswana Combination Prevention Project Research Data Network
Presenter: Erik van Widenfelt

Low rates of cholesterol screening despite cardiovascular risk in protease inhibitor-treated HIV patients in Botswana
Presenter: Mosepele Mosepele

Demonstrating regulatory compliance of a novel electronic data management system in large scale community-based HIV prevention trial in Botswana
Presenter: Tumalano Sekoto

Estimation of HIV incidence using retrospectively-collected HIV testing history in Botswana
Presenter: Nadia N. Abuelezam

Cross-sectional estimates of HIV incidence remain high in rural communities in Botswana in the era of successful scale up of ART
Presenter: Sikhulile Moyo

Comparison of neurodevelopmental outcomes between HIV-exposed uninfected infants vs. HIV-unexposed infants
Presenter: Jean Leidner

Harvard University's nationwide response to HIV/AIDS in Botswana, September, 2015. Photo © Dominic Chavez
Sikhulile Moyo

Monitoring of HIV-1 RNA with point-of-care cepheid Xpert HIV-1 viral load in rural African communities is feasible and reliable in the era of broad scale up of ART
Presenter: Sikhulile Moyo

High proportion of deaths attributable to HIV among post-partum women in Botswana despite widespread uptake of ART
Presenter: Rebecca Zash

Community engagement in research unearths community health needs
Presenter: Ernest Mosimanegape Moseki

Response to Truvada based cART in HIV/HBV co-infected patients in Botswana
Presenter: Motswedi Anderson

Predominance of hepatitis B virus genotype D in HIV-1 subtype C co-infected patients with occult hepatitis B in Botswana
Presenter: Simani Gaseitsiwe

Dr. Kate Powis
Dr. Kate Powis

Increased risk of morbidity/mortality among formula fed HIV-exposed uninfected infants in socioeconomically challenged households in Botswana: findings from the Mpepu study
Presenter: Kathleen Powis

The endotoxin-lipoprotein hypothesis, obesity and HIV
Presenter: Sabrina Martinez

Randomized trial of stopping or continuing ART among post-partum women with pre-ART CD4 > 400 cells/mm (PROMISE 1077HS)
Presenter: Judith Currier

Low acceptance of early antiretroviral therapy (ART) among post-partum women enrolled in IMPAACT PROMISE studies across the globe
Presenter: Lynda Stranix-Chibanda

Title image: The Botswana Combination Prevention Project leadership team meets in the Botswana Harvard AIDS Institute conference room. Photo by Dominic Chavez